Beranda › Disfungsi Ventrikel Kiri › New York › The Bronx
Uji klinis Disfungsi Ventrikel Kiri di The Bronx, NY
3 studi untuk Disfungsi Ventrikel Kiri mencari peserta di lokasi sekitar The Bronx (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Menerima pesertaFase 2/3
- The Children's Hospital at Montefiore ( Site 0030), The Bronx
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- The Children's Hospital at Montefiore - Cardiology, The Bronx
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- The Children's Hospital at Montefiore - Cardiology, The Bronx
Uji klinis Disfungsi Ventrikel Kiri di kota lain
- New York City, NY4 studi
- Cleveland, OH4 studi
- Atlanta, GA3 studi
- St. Louis, MO3 studi
- Aurora, CO3 studi
- Pittsburgh, PA3 studi
- Dallas, TX3 studi
- Houston, TX3 studi
- Philadelphia, PA3 studi
- Cincinnati, OH3 studi
- Ann Arbor, MI3 studi
- Boston, MA3 studi
Studi lain di The Bronx
- Kanker Paru Non-Sel Kecil25 studi
- Kanker Payudara17 studi
- Leukemia Mieloid Akut15 studi
- Kanker Paru13 studi
- Penyakit Kardiovaskular12 studi
- Kanker (semua jenis)12 studi
- Gagal Jantung11 studi
- Kanker Prostat11 studi
- Karsinoma Sel Skuamosa Kepala dan Leher9 studi
- Sindrom Mielodisplastik9 studi
- Kanker Kolorektal9 studi
- Asma9 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.